Techseriesinsight
  • Home
  • News
    • Advertising & Promotion
      • Content Marketing
      • Marketing Automation
      • Press Release
      • Sales & Marketing
      • Social Media
    • Analytics
      • Cloud
      • Data Center
      • Data Management Platform
      • Storage
    • Artificial Intelligence
      • RoboticsExplore the latest in robotics tech news. Stay updated on innovations, trends, and developments in this exciting field.
    • Biotechnology
    • Business Broadcast
    • Customer Experience
    • E-Commerce
    • Healthcare
    • Joint Ventures
    • Networking
      • Blockchain TechnologyBlockchain Technology
      • Internet of Things (IoT)Internet of Things (IoT)
    • Security
  • Insights
  • Resource Hub
    • AI / ML
    • Cloud Technology
    • Customer Engagement
    • Information Technology
    • Security
    • Tech & Work
Techseriesinsight
Techseriesinsight
  • Home
  • News
    • Advertising & Promotion
      • Content Marketing
      • Marketing Automation
      • Press Release
      • Sales & Marketing
      • Social Media
    • Analytics
      • Cloud
      • Data Center
      • Data Management Platform
      • Storage
    • Artificial Intelligence
      • RoboticsExplore the latest in robotics tech news. Stay updated on innovations, trends, and developments in this exciting field.
    • Biotechnology
    • Business Broadcast
    • Customer Experience
    • E-Commerce
    • Healthcare
    • Joint Ventures
    • Networking
      • Blockchain TechnologyBlockchain Technology
      • Internet of Things (IoT)Internet of Things (IoT)
    • Security
  • Insights
  • Resource Hub
    • AI / ML
    • Cloud Technology
    • Customer Engagement
    • Information Technology
    • Security
    • Tech & Work

Biotechnology

Techseriesinsight > Blog > News > Biotechnology
EIT Pharma Closes Oversubscribed
  • August 31, 2026
  • PRNewswire
  • Biotechnology, News

EIT Pharma Closes Oversubscribed $35 Million Series A Round, Led by Propel Bio Partners

EIT Pharma, Inc. (“EIT Pharma” or the “Company”), a biotechnology company focused on developing therapies for infectious diseases, today announced the successful close of an oversubscribed $35 million Series...
Continue Reading
Maxis AI Introduces the First Verticalized Context
  • August 25, 2026
  • Business Wire
  • Biotechnology, News

Maxis AI Introduces the First Verticalized Context Layer for Life Sciences, a Governed Execution Fabric That Makes Enterprise AI Reliable, Cost-Efficient, and Regulatory Compliant

Maxis AI today introduced MaxisAI Holarchy, its Verticalized Context Layer, a governed institutional memory that gives life sciences enterprises the trusted organizational context AI agents need to support clinical execution across...
Continue Reading
Orchestra Life Sciences Named No. 203 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
  • August 13, 2026
  • Business Wire
  • Biotechnology, News

Jupiter Endovascular Appoints Catalin Toma, MD, as Chief Medical Officer

Jupiter Endovascular Inc., a medical technology company developing a new class of endovascular interventions based on its proprietary Transforming Fixation (TFX) technology, today announced the appointment of renowned interventional...
Continue Reading
Orchestra Life Sciences Named
  • August 11, 2026
  • PRNewswire
  • Biotechnology, News

Orchestra Life Sciences Named No. 203 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

Orchestra Life Sciences, a technical consultancy specializing in advanced therapy manufacturing solutions, today announced that it has been ranked No. 203 on the 2026 Inc. 5000 list, the annual ranking...
Continue Reading
SonicWall Earns Clean Sweep of 2026 CRN Annual Report Card
  • August 10, 2026
  • PRNewswire
  • Biotechnology, News

Acarix Receives Regulatory Approval for the CADScor® System in the UAE

Acarix AB (publ) today announced that the CADScor® System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the way...
Continue Reading
Caris Precision Oncology Alliance Welcomes the University
  • August 7, 2026
  • PRNewswire
  • Biotechnology, News

Caris Precision Oncology Alliance Welcomes the University of New Mexico Comprehensive Cancer Center

Caris Life Sciences® (Caris), a leading TechBio company, today announced that the University of New Mexico Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance® (Caris POA), a global...
Continue Reading
Clinilabs Announces Medical Leadership Appointments
  • August 5, 2026
  • Business Wire
  • Biotechnology, News

Clinilabs Announces Medical Leadership Appointments

Clinilabs, a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar...
Continue Reading
AsymBio Secures US$184 Million
  • August 4, 2026
  • PRNewswire
  • Biotechnology, News

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group, today announced a total capital injection of RMB 1.2397 billion (approximately US$184 million) into AsymBio...
Continue Reading
QuantHealth Raises $45 Million Series B
  • August 4, 2026
  • Business Wire
  • Biotechnology, News

QuantHealth Raises $45 Million Series B, led by Qumra Capital, to Accelerate Simulation-First Clinical Trial Development

QuantHealth, a global leader in AI-driven clinical trial simulation, today announced a $45 million Series B. The round was led by Qumra Capital, with support from additional investors, including Pitango...
Continue Reading
Decoy Therapeutics Expands
  • August 3, 2026
  • PRNewswire
  • Biotechnology, News

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced continued expansion of its intellectual property portfolio, which now comprises seven patent families covering compositions of...
Continue Reading

Posts navigation

Previous 1 2 3 4 … 50 Next

Search

Newsletter

Subscribe Our Free Newsletter

Loading

Get in Touch

  • 750 Followers
  • 950 Likes
  • 1250 Fans
  • 1050 Followers

Recent Posts

Kaiser Permanente invests $15M for behavioral health care
Kaiser Permanente invests $15M for behavioral… October 28, 2026
Wealthbox Launches Vault, Advanced File Storage for Advisory
Wealthbox Launches Vault, Advanced File Storage… October 28, 2026
Formation Bio
Formation Bio Announces $600 Million Debut… October 28, 2026
NiCE Publishes 2025 Environmental, Social and Governance
Netrio Recognized on the CRN® AI… October 28, 2026
Stellar
Movantis Integrates with the Stellar Network… October 28, 2026

Hot Categories

Techseriesinsight

Techseriesinsight is a global digital platform that publishes content related to technology and business insights from industry experts. Get the latest news, discussions & strategic expertise with thoughts and assessments on business challenges.

Follow us

Quick links

  • Contact Us
  • Privacy Policy
  • Unsubscribe

Subscribe Our Free Newsletter

Loading

Techseriesinsight, 2026 © All Rights Reserved